Merck and Moderna's Melanoma Vaccine Shows Promise

Pharmaceutical giants Merck and Moderna have reported promising results from their melanoma vaccine.

The news was announced on August 19, with both companies stating that their vaccine has shown significant potential in treating the deadly skin cancer.

Melanoma is one of the most aggressive forms of skin cancer, with a high mortality rate. The development of an effective vaccine could be a major breakthrough in the fight against this disease.